Advances and Challenges in the Prevention and Treatment of Alzheimer's Disease
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 15 (3) , 386-398
- https://doi.org/10.1023/a:1011963929012
Abstract
Alzheimer's disease (AD) is the most common cause of dementia and accounts for one-half to three-fourths of all cases of dementia. In the United States, AD is the leading cause of a loss of...Keywords
This publication has 79 references indexed in Scilit:
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Oxidative damage in Alzheimer'sNature, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrainNeuron, 1995
- Oral Administration of NGF Synthesis Stimulators Recovers Reduced Brain NGF Content in Aged Rats and Cognitive Dysfunction in Basal – Forebrain – Lesioned RatsGerontology, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Localization of DNase I hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promotersJournal of Molecular Endocrinology, 1993
- Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In VitroJournal of Neurochemistry, 1990
- Epidemiology of dementia in a Finnish populationActa Neurologica Scandinavica, 1982